Drug Trial Radar · NCT03525119
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine
Last checked: Nov 19, 2026Latest source record: Aug 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
900
Actual
Start
May 16, 2018
Primary completion
Oct 3, 2018
Study completion Jul 9, 2019
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the immunogenicity and safety of the concomitant administration of TDV (subcutaneous \[SC\] injection) and of hepatitis A virus (HAV) vaccine (intramuscular \[IM\] injection) in healthy participants aged 18 to 60 years living in country(ies) non-endemic for both dengue and hepatitis.
Conditions
- Healthy Volunteers
Interventions
TDVBiological
TDV SC injection
HAV VaccineBiological
HAV Vaccine IM injection.
TDV PlaceboBiological
Placebo-matching (normal saline (0.9% NaCl) SC injection.
HAV Vaccine PlaceboBiological
Placebo-matching (normal saline (0.9% NaCl) IM injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants HAV/Dengue Virus (DENV)-Naive at Baseline Who Are Seroprotected Against HAV at Day 30Time frame: One month post first vaccination (Day 30)
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Synexus - Wales
Cardiff, United Kingdom
Synexus - Scotland
Glasgow, United Kingdom
North East Clinical Research Centre, Hexham General Hospital
Hexham, United Kingdom
Synexus - Manchester
Manchester, United Kingdom
Synexus - Thames Valley
Reading, United Kingdom
North Tees Clinical Research Centre, Middlefield Centre, University Hospital of North Tees
Stockton-on-Tees, United Kingdom
Synexus - Midlands
Edgbaston, Birmingham, United Kingdom
Synexus - Lancashire
Chorley, Lancashire, United Kingdom
Synexus - Merseyside
Waterloo, Liverpool, United Kingdom
Royal Hallamshire Hospital
Sheffield, Yorkshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.